Oxfordshire, United Kingdom

Paula C De Aguiar Pena

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 7.6

ph-index = 5

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: The Innovative Contributions of Paula C De Aguiar Pena

Introduction

Paula C De Aguiar Pena is a prominent inventor based in Oxfordshire, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neurodegenerative disorders. With a total of 8 patents to her name, her work is recognized for its potential impact on patient care.

Latest Patents

Her latest patents focus on Kynurenine-3-monooxygenase (KMO) inhibitors, which are crucial in the treatment of various diseases and disorders. These patents describe certain chemical entities that can be used in pharmaceutical compositions. The methods outlined in her patents include administering these chemical entities to patients suffering from conditions responsive to the inhibition of KMO activity. Notably, her work addresses neurodegenerative disorders such as Huntington's disease. The patents also detail methods for screening compounds capable of inhibiting KMO activity, showcasing her innovative approach to drug development.

Career Highlights

Paula is currently associated with the CHDI Foundation, Inc., where she continues to advance her research and development efforts. Her career is marked by a commitment to improving therapeutic options for patients with challenging health conditions.

Collaborations

Throughout her career, Paula has collaborated with notable colleagues, including Celia Dominguez and Leticia M Toledo-Sherman. These partnerships have further enriched her research and contributed to the success of her projects.

Conclusion

Paula C De Aguiar Pena's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly in the area of KMO inhibitors, hold promise for the treatment of neurodegenerative disorders. Through her patents and collaborations, she continues to make a significant impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…